Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P1.04 - Immuno-oncology
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 0
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.04-14 - Early Changes in Plasma CXCL2 and MMP2 Levels Predicts the Response to Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer
09:45 - 09:45 | Presenter: Norikazu Matsuo
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
- Presentations: 0
- Coordinates: 9/08/2019, 09:45 - 18:00, Exhibit Hall
-
+
P1.14-30 - Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
09:45 - 09:45 | Presenter: Takaaki Tokito
- Abstract
Loading...
-
+
OA02 - A New Vision of Targets and Strategies
- Type: Oral Session
- Track: Targeted Therapy
- Presentations: 1
- Now Available
- Moderators:Frank Griesinger
- Coordinates: 9/08/2019, 10:30 - 12:00, Seoul (2007)
-
+
OA02.06 - The Sequential Therapy of Crizotinib Followed by Alectinib: Real World Data of 840 Patients with NSCLC Harboring ALK-Rearrangement (WJOG9516L) (Now Available)
11:25 - 11:35 | Presenter: Satomi Watanabe
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.04 - Immuno-oncology
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.04-01 - Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC
10:15 - 10:15 | Presenter: Koichi Azuma
- Abstract
Loading... -
+
P2.04-85 - Clinical Significance of the PD-L2 Expression in Patients with NSCLC Receiving Anti-PD-1 Inhibitors
10:15 - 10:15 | Presenter: Hidenobu Ishii
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.14-52 - The Results from Plasma EGFR Mutation Analysis in NEJ026 Study
10:15 - 10:15 | Presenter: Tatsuro Fukuhara
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- Type: Mini Oral Session
- Track: Targeted Therapy
- Presentations: 1
- Now Available
- Moderators:Benjamin Besse
- Coordinates: 9/10/2019, 14:30 - 16:00, Vienna (2016)
-
+
MA21.11 - A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425 (Now Available)
15:40 - 15:45 | Presenter: Sakiko Otani
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
